Hypertension Treatment in Patients with Metabolic Syndrome and/or Type 2 Diabetes Mellitus: Analysis of the Therapy Effectivity and the Therapeutic Inertia in Outpatient Study

<div>The most significant decrease of sBP and dBP associated with certain drugs (in mmHg). Nitren. = nitrendipine, hydro. = hydrochlorothiazide, telmis. = telmisartan, urapid. = urapidil, irbes. = irbesartan, indap. = indapamide, verap. = verapamil, nebiv. = nebivolol, spiron. = spironolactone, and rilmen. = rilmenidine.</div>

Cardiology Research and Practice

fig7

Figure 7

Figure 7: Hypertension Treatment in Patients with Metabolic Syndrome and/or Type 2 Diabetes Mellitus: Analysis of the Therapy Effectivity and the Therapeutic Inertia in Outpatient Study 

Figure 7 | Hypertension Treatment in Patients with Metabolic Syndrome and/or Type 2 Diabetes Mellitus: Analysis of the Therapy Effectivity and the Therapeutic Inertia in Outpatient Study 